Invasive lobular breast carcinoma

MONDO:0005051

An infiltrating lobular adenocarcinoma of the breast. The malignant cells lack cohesion and are arranged individually or in a linear manner (Indian files), or as narrow trabeculae within the stroma. The malignant cells are usually smaller than those of ductal carcinoma, are less pleomorphic, and have fewer mitotic figures.

Also known as: lobular carcinoma, lobular carcinoma (morphologic abnormality), lobular carcinoma NOS (morphologic abnormality), lobular carcinoma of the breast, classic invasive lobular carcinoma, infiltrating lobular adenocarcinoma, infiltrating lobular breast carcinoma, infiltrating lobular carcinoma of breast

2837 clinical trials for this condition and its sub-types, 30 tagged with Invasive lobular breast carcinoma itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Invasive breast carcinoma (413) ↑ Breast lobular carcinoma (34)

Including sub-types (2837) Tagged with Invasive lobular breast carcinoma (30)

Trials to join now! 15 Not yet recruiting 4 Not yet finished but already full! 7 Completed 3 Terminated 1

Promising breast cancer combo trial halted early – only 6 patients enrolled

Disease control Stopped early

This phase 2 trial tested repotrectinib with or without fulvestrant in people with a rare, hormone-positive, HER2-negative metastatic breast cancer called invasive lobular carcinoma. The goal was to see if the combination could control the disease after standard treatments had st…

Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 08:09 UTC

Invasive lobular breast carcinoma

Where it sits in the disease tree

Promising breast cancer combo trial halted early – only 6 patients enrolled